Vendeur
GreatBookPricesUK, Woodford Green, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Vendeur AbeBooks depuis 28 janvier 2020
Unread book in perfect condition. N° de réf. du vendeur 35510024
Remarkable advances have occurred since the Series 3 Fascicle published in 1995 with paradigm shifts in every dimension of our understanding of lung tumors including clinical, radiologic, histopathologic, cytopathologic, immunohistochemical, molecular and therapeutic aspects. The molecular revolution leading to effective targeted therapies and breakthroughs in immunotherapy for lung cancer have led to novel approaches incorporating the concept of personalized medicine for patients who historically had little hope. These advances have strengthened the place of pathologists to play a central role in the multidisciplinary team that is now needed to properly diagnose and manage lung cancer patients.
À propos de l'auteur:
William D. Travis, MD, Director, Thoracic Pathology, Attending Thoracic Pathologist, Memorial Sloan Kettering Cancer Center, New York.
Andrew G. Nicholson , MBBS, MA, DM, FRCPath, Consultant Histopathologist, Royal Brompton and Harefield Hospitals NHS Foundation Trust, and Honorary Professor of Respiratory Pathology, National Heart and Lung Division, Imperial College, London, UK.
Kim R. Geisinger , MD, Professor of Pathology, University of Mississippi Medical Center, Jackson, Mississippi.
Elisabeth Brambilla, MD, PhD, Emeritus Professor of Pathology, University Grenoble Alpes-CHUGA, Grenoble, France.
Titre : Tumors Of The Lower Respiratory Tract
Éditeur : American Registry of Pathology
Date d'édition : 2019
Reliure : Couverture rigide
Etat : As New